SPI

SPI handeln
18.574,54 PKT -62,04 PKT -0,33 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 998750

ISIN CH0009987501


Analysen zu SPI-Werten

Datum Rating Analyst
06.07.23 ABB (Asea Brown Boveri) Outperform RBC Capital Markets
06.07.23 Roche Underweight JP Morgan Chase & Co.
05.07.23 ABB (Asea Brown Boveri) Equal Weight Barclays Capital
05.07.23 Roche Hold Jefferies & Company Inc.
05.07.23 Novartis Buy Jefferies & Company Inc.
04.07.23 Givaudan Add Baader Bank
04.07.23 Richemont Market-Perform Bernstein Research
04.07.23 Nestlé Market-Perform Bernstein Research
04.07.23 UBS Buy Deutsche Bank AG
03.07.23 Richemont Buy UBS AG
03.07.23 ABB (Asea Brown Boveri) Hold Deutsche Bank AG
03.07.23 Givaudan Sell Goldman Sachs Group Inc.
03.07.23 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
30.06.23 Richemont Neutral Credit Suisse Group
30.06.23 UBS Sector Perform RBC Capital Markets
30.06.23 Richemont Overweight Barclays Capital
30.06.23 Nestlé Underperform RBC Capital Markets
30.06.23 ams-OSRAM Hold Jefferies & Company Inc.
29.06.23 DocMorris Hold Deutsche Bank AG
29.06.23 Roche Underweight JP Morgan Chase & Co.
28.06.23 Richemont Conviction Buy List Goldman Sachs Group Inc.
28.06.23 Nestlé Market-Perform Bernstein Research
28.06.23 Nestlé Market-Perform Bernstein Research
28.06.23 Richemont Outperform RBC Capital Markets
28.06.23 ABB (Asea Brown Boveri) Hold Jefferies & Company Inc.
27.06.23 Nestlé Underperform RBC Capital Markets
26.06.23 Givaudan Sell UBS AG
26.06.23 UBS Underweight Barclays Capital
23.06.23 Givaudan Hold Deutsche Bank AG
23.06.23 Givaudan Sell UBS AG
22.06.23 Givaudan Neutral JP Morgan Chase & Co.
22.06.23 Roche Sell Deutsche Bank AG
22.06.23 UBS Overweight JP Morgan Chase & Co.
22.06.23 Richemont Overweight JP Morgan Chase & Co.
21.06.23 DocMorris Buy Warburg Research
20.06.23 Roche Sell Deutsche Bank AG
16.06.23 Givaudan Sell Goldman Sachs Group Inc.
15.06.23 Novartis Underweight Barclays Capital
15.06.23 Roche Neutral UBS AG
15.06.23 Novartis Neutral UBS AG